India Personalized Genetic Testing Market Size, Trends & Analysis - Forecasts to 2029 By Test Type (Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, and Others), By Technology (PCR-based Tests, Microarray-based Tests, Sequencing-based Tests, and Others ), By Application (Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition & Health Lifestyle, and Others), and By End User (Hospitals & Clinics, Research Centers, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Others), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The India personalized genetic testing market is projected to grow at a CAGR of 11.9% from 2024 to 2029.
People are becoming increasingly curious about their genetic composition and how it affects their history, lifestyle, and health. The increased demand for these testing services is partly due to the growing awareness of the importance of proactive health management and the general interest in tailored information. There is an increasing need for early detection and therapy of genetic illnesses, such as thalassemia, due to their rising prevalence in India. This increased frequency highlights the necessity of customized genetic testing, which gives people important information to make decisions and take preventative healthcare actions in the event of a hereditary illness.
Personalized genetic testing is becoming more widespread due to technological breakthroughs and falling DNA sequencing prices. These tests are now much more common and available to a larger portion of the public due to the declining barrier to affordability. Interest in genetic data has grown as personalized treatment and healthcare become more popular. Understanding a person's genetic predispositions through personalized genetic testing enables more individualized and preventive healthcare approaches.
Genetic testing services are becoming more easily accessible in India due to the combination of telemedicine and digital health platforms. These technologies improve convenience for people looking for genetic testing by enabling remote consultations and sample collection, which positively impacts the market's growth.
The adoption of digital technologies facilitates easier access to genetic data. It allows consumers to interact with testing services from the comfort of their homes, supporting the nation's personalized genetic testing market's overall growth.
A larger portion of the population may not be able to obtain personalized genetic testing due to the high costs involved. The high price may make things financially difficult for some people, limiting market expansion.
The oncology testing segment is expected to hold the largest share of the market over the forecast period. This is attributed to the increasing prevalence of cancer cases. Personalized genetic testing is in high demand to determine the genetic factors impacting cancer susceptibility and response to therapy since cancer is still a major public health concern.
The infectious disease testing segment is expected to be the fastest-growing segment of the market from 2024-2029. Personalized genetic testing is gaining traction as preventative healthcare, particularly concerning infectious diseases. Genetic marker identification linked to infectious diseases can now be done more quickly and accurately due to genetic technology advancements. The rapid expansion of the segment can also be attributed to the increased necessity of genetic testing for prompt diagnosis.
The sequencing-based tests segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. The segment's growth is attributed to advances in DNA sequencing technology, such as next-generation sequencing, which helps to provide precise and complete genetic analysis. Demand for sequencing-based tests is increasing due to new applications in disease risk assessment, pharmacogenomics, and ancestry testing. The segment's rapid expansion is being driven by technology advancements, expanded research programs, and the growing use of genomic data for individualized healthcare decisions.
The microarray-based tests segment is expected to hold the largest share of the market. The anticipated segment growth is due to its ability to analyze several genetic variants simultaneously. Microarray technology allows for high-throughput analysis, making it possible to examine a large number of genetic markers efficiently.
The precision medicine segment is anticipated to be the fastest-growing segment in the market from 2024-2029. The segment's growth is attributed to the increased usage of individualized treatment approaches. Precision medicine uses genetic information to personalize medical interventions to each individual's unique genetic profile. As awareness rises and healthcare professionals optimize precision medicine to enhance treatment outcomes, there is a heightened need for genetic testing to guide individualized therapeutic tactics, thus contributing to segment growth.
The diagnostics segment is expected to hold the largest share of the market. This is due to due to the increasing adoption of genetic tests for disease risk assessment, early detection, and personalized treatment planning. Furthermore, genetic technology advances improve diagnostic tests' accuracy and usefulness, further contributing to the segment's growth.
The diagnostic laboratories segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. The segment's growth is due to increased outsourcing of genetic testing services to specialized laboratories. Diagnostic laboratories provide efficient and dedicated genetic testing services, contributing to their growing popularity.
The hospitals & clinics segment is expected to hold the largest share of the market. Hospitals and clinics are priorities for patient care, diagnosis, and treatment. The growing incorporation of customized genetic testing into standard clinical practices and greater knowledge of genetic testing benefits place hospitals and clinics as essential end users.
Semantic Web India, Bayes Labs, Orbuculum, Precision Health Innovations Pvt Ltd, Theomics International Private Limited, Genetico, ArrayGen Technologies, D-NOME PRIVATE LIMITED, Eurofins, and Genes2Me, among others, are some of the key players operating in the India personalized genetic testing market.
Please note: This is not an exhaustive list of companies profiled in the report.
In November 2022, Dana-Farber Cancer Institute highlighted the launch of a cancer risk screening tool called MyLynch by the Bayes-Mendel Lab. MyLynch is designed for individuals with Lynch syndrome, a hereditary condition linked to an increased risk of various cancers. The tool aims to bridge communication between patients and their family doctors, providing personalized risk profiles and facilitating discussions on preventive measures.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Test Types
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 INDIA MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 INDIA PERSONALIZED GENETIC TESTING MARKET, BY TEST TYPE
4.1 Introduction
4.2 Personalized Genetic Testing Market: Test Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Oncology Testing
4.4.1 Oncology Testing Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Infectious Disease Testing
4.5.1 Infectious Disease Testing Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Neurological Testing
4.6.1 Neurological Testing Market Estimates and Forecast, 2021-2029 (USD Million)
4.7 Cardiovascular Testing
4.7.1 Cardiovascular Testing Market Estimates and Forecast, 2021-2029 (USD Million)
4.8 Others
4.8.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
5 INDIA PERSONALIZED GENETIC TESTING MARKET, BY TECHNOLOGY
5.1 Introduction
5.2 Personalized Genetic Testing Market: Technology Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 PCR-based Tests
5.4.1 PCR-based Tests Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Microarray-based Tests
5.5.1 Microarray-based Tests Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Sequencing-based Tests
5.6.1 Sequencing-based Tests Market Estimates and Forecast, 2021-2029 (USD Million)
5.7 Others
5.7.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
6 INDIA PERSONALIZED GENETIC TESTING MARKET, BY APPLICATION
6.1 Introduction
6.2 Personalized Genetic Testing Market: Application Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 Diagnostics
6.4.1 Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.5 Precision Medicine
6.5.1 Precision Medicine Market Estimates and Forecast, 2021-2029 (USD Million)
6.6 Wellness
6.6.1 Wellness Market Estimates and Forecast, 2021-2029 (USD Million)
6.7 Reproductive Health
6.7.1 Reproductive Health Market Estimates and Forecast, 2021-2029 (USD Million)
6.8 Sports Nutrition & Health Lifestyle
6.8.1 Sports Nutrition & Health Lifestyle Market Estimates and Forecast, 2021-2029 (USD Million)
6.9 Others
6.9.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
7 INDIA PERSONALIZED GENETIC TESTING MARKET, BY END USER
7.1 Introduction
7.2 Personalized Genetic Testing Market: End User Scope Key Takeaways
7.3 Revenue Growth Analysis, 2023 & 2029
7.4 Hospitals & Clinics
7.4.1 Hospitals & Clinics Market Estimates and Forecast, 2021-2029 (USD Million)
7.5 Research Centers
7.5.1 Research Centers Market Estimates and Forecast, 2021-2029 (USD Million)
7.6 Pharmaceutical & Biotechnology Companies
7.6.1 Pharmaceutical & Biotechnology Companies Market Estimates and Forecast, 2021-2029 (USD Million)
7.7 Diagnostic Laboratories
7.7.1 Diagnostic Laboratories Market Estimates and Forecast, 2021-2029 (USD Million)
7.8 Others
7.8.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
8 COMPETITIVE LANDCAPE
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.2.1 Market Leaders
8.2.2 Market Visionaries
8.2.3 Market Challengers
8.2.4 Niche Market Players
8.3 Vendor Landscape
8.3.1 India
8.4 Company Profiles
8.4.1 Semantic Web India
8.4.1.1 Business Description & Financial Analysis
8.4.1.2 SWOT Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 Bayes Labs
8.4.2.1 Business Description & Financial Analysis
8.4.2.2 SWOT Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3 Orbuculum
8.4.3.1 Business Description & Financial Analysis
8.4.3.2 SWOT Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4 Precision Health Innovations Pvt Ltd
8.4.4.1 Business Description & Financial Analysis
8.4.4.2 SWOT Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 Genetico
8.4.5.1 Business Description & Financial Analysis
8.4.5.2 SWOT Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6 THEOMICS INTERNATIONAL PRIVATE LIMITED
8.4.6.1 Business Description & Financial Analysis
8.4.6.2 SWOT Analysis
8.4.6.3 Products & Services Offered
8.4.6.4 Strategic Alliances between Business Partners
8.4.7 ArrayGen Technologies
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 D-NOME PRIVATE LIMITED
8.4.8.1 Business Description & Financial Analysis
8.4.8.2 SWOT Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9 Eurofins
8.4.9.1 Business Description & Financial Analysis
8.4.9.2 SWOT Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10 Genes2Me
8.4.10.1 Business Description & Financial Analysis
8.4.10.2 SWOT Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11 Other Companies
8.4.11.1 Business Description & Financial Analysis
8.4.11.2 SWOT Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9 RESEARCH METHODOLOGY
9.1 Market Introduction
9.1.1 Market Definition
9.1.2 Market Scope & Segmentation
9.2 Information Procurement
9.2.1 Secondary Research
9.2.1.1 Purchased Databases
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2 Primary Research
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.3 Primary Stakeholders
9.2.2.4 Discussion Guide for Primary Participants
9.2.3 Expert Panels
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4 Paid Local Experts
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3 Market Estimation
9.3.1 Top-Down Approach
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2 Bottom Up Approach
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4 Data Triangulation
9.4.1 Data Collection
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.4.3 Cluster Analysis
9.5 Analysis and Output
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
9.7.1 Research Assumptions
9.7.2 Research Limitations
LIST OF TABLES
1 India Personalized Genetic Testing Market, By Test Type, 2021-2029 (USD Million)
2 Oncology Testing Market, By Country, 2021-2029 (USD Million)
3 Infectious Disease Testing Market, By Country, 2021-2029 (USD Million)
4 Neurological Testing Market, By Country, 2021-2029 (USD Million)
5 Cardiovascular Testing Market, By Country, 2021-2029 (USD Million)
6 Others Market, By Country, 2021-2029 (USD Million)
7 India Personalized Genetic Testing Market, By Technology, 2021-2029 (USD Million)
8 PCR-based Tests Market, By Country, 2021-2029 (USD Million)
9 Microarray-based Tests Market, By Country, 2021-2029 (USD Million)
10 Sequencing-based Tests Market, By Country, 2021-2029 (USD Million)
11 Others Market, By Country, 2021-2029 (USD Million)
12 India Personalized Genetic Testing Market, By Application, 2021-2029 (USD Million)
13 Diagnostics Market, By Country, 2021-2029 (USD Million)
14 Precision Medicine Market, By Country, 2021-2029 (USD Million)
15 Wellness Market, By Country, 2021-2029 (USD Million)
16 Reproductive Health Market, By Country, 2021-2029 (USD Million)
17 Sports Nutrition & Health Lifestyle Market, By Country, 2021-2029 (USD Million)
18 Others Market, By Country, 2021-2029 (USD Million)
19 India Personalized Genetic Testing Market, By End User, 2021-2029 (USD Million)
20 Hospitals & Clinics Market, By Country, 2021-2029 (USD Million)
21 Research Centers Market, By Country, 2021-2029 (USD Million)
22 Pharmaceutical & Biotechnology Companies Market, By Country, 2021-2029 (USD Million)
23 Diagnostic Laboratories Market, By Country, 2021-2029 (USD Million)
24 Others Market, By Country, 2021-2029 (USD Million)
25 Semantic Web India: Products & Services Offering
26 Bayes Labs: Products & Services Offering
27 Orbuculum: Products & Services Offering
28 Precision Health Innovations Pvt Ltd: Products & Services Offering
29 Genetico: Products & Services Offering
30 THEOMICS INTERNATIONAL PRIVATE LIMITED: Products & Services Offering
31 ArrayGen Technologies : Products & Services Offering
32 D-NOME PRIVATE LIMITED: Products & Services Offering
33 Eurofins, Inc: Products & Services Offering
34 Genes2Me: Products & Services Offering
35 Other Companies: Products & Services Offering
LIST OF FIGURES
1 India Personalized Genetic Testing Market Overview
2 India Personalized Genetic Testing Market Value From 2021-2029 (USD Million)
3 India Personalized Genetic Testing Market Share, By Test Type (2023)
4 India Personalized Genetic Testing Market Share, By Technology (2023)
5 India Personalized Genetic Testing Market Share, By Application (2023)
6 India Personalized Genetic Testing Market Share, By End User (2022)
7 India Personalized Genetic Testing Market, By Country
8 Technological Trends In India Personalized Genetic Testing Market
9 Four Quadrant Competitor Positioning Matrix
10 Impact Of Macro & Micro Indicators On The Market
11 Impact Of Key Drivers On The India Personalized Genetic Testing Market
12 Impact Of Challenges On The India Personalized Genetic Testing Market
13 Porter’s Five Forces Analysis
14 India Personalized Genetic Testing Market: By Test Type Scope Key Takeaways
15 India Personalized Genetic Testing Market, By Test Type Segment: Revenue Growth Analysis
16 Oncology Testing Market, By Country, 2021-2029 (USD Million)
17 Infectious Disease Testing Market, By Country, 2021-2029 (USD Million)
18 Neurological Testing Market, By Country, 2021-2029 (USD Million)
19 Cardiovascular Testing Market, By Country, 2021-2029 (USD Million)
20 Others Market, By Country, 2021-2029 (USD Million)
21 India Personalized Genetic Testing Market: By Technology Scope Key Takeaways
22 India Personalized Genetic Testing Market, By Technology Segment: Revenue Growth Analysis
23 PCR-based Tests Market, By Country, 2021-2029 (USD Million)
24 Microarray-based Tests Market, By Country, 2021-2029 (USD Million)
25 Sequencing-based Tests Market, By Country, 2021-2029 (USD Million)
26 Others Market, By Country, 2021-2029 (USD Million)
27 India Personalized Genetic Testing Market: By Application Scope Key Takeaways
28 India Personalized Genetic Testing Market, By Application Segment: Revenue Growth Analysis
29 Diagnostics Market, By Country, 2021-2029 (USD Million)
30 Precision Medicine Market, By Country, 2021-2029 (USD Million)
31 Wellness Market, By Country, 2021-2029 (USD Million)
32 Reproductive Health Market, By Country, 2021-2029 (USD Million)
33 Sports Nutrition & Health Lifestyle Market, By Country, 2021-2029 (USD Million)
34 Others Market, By Country, 2021-2029 (USD Million) India Personalized Genetic Testing Market: By End User Scope Key Takeaways
35 India Personalized Genetic Testing Market, By End User Segment: Revenue Growth Analysis
36 Hospitals & Clinics Market, By Country, 2021-2029 (USD Million)
37 Research Centers Market, By Country, 2021-2029 (USD Million)
38 Pharmaceutical & Biotechnology Companies Market, By Country, 2021-2029 (USD Million)
39 Diagnostic Laboratories Market, By Country, 2021-2029 (USD Million)
40 Others Market, By Country, 2021-2029 (USD Million)
41 Regional Segment: Revenue Growth Analysis
42 India Personalized Genetic Testing Market: Regional Analysis
43 India Personalized Genetic Testing Market Overview
44 India Personalized Genetic Testing Market, By Test Type
45 India Personalized Genetic Testing Market, By Technology
46 India Personalized Genetic Testing Market, By Application
47 India Personalized Genetic Testing Market, By End User
48 Four Quadrant Positioning Matrix
49 Company Market Share Analysis
50 Semantic Web India: Company Snapshot
51 Semantic Web India: SWOT Analysis
52 Semantic Web India: Geographic Presence
53 Bayes Labs: Company Snapshot
54 Bayes Labs: SWOT Analysis
55 Bayes Labs: Geographic Presence
56 Orbuculum: Company Snapshot
57 Orbuculum: SWOT Analysis
58 Orbuculum: Geographic Presence
59 Precision Health Innovations Pvt Ltd: Company Snapshot
60 Precision Health Innovations Pvt Ltd: Swot Analysis
61 Precision Health Innovations Pvt Ltd: Geographic Presence
62 Genetico: Company Snapshot
63 Genetico: SWOT Analysis
64 Genetico: Geographic Presence
65 THEOMICS INTERNATIONAL PRIVATE LIMITED: Company Snapshot
66 THEOMICS INTERNATIONAL PRIVATE LIMITED: SWOT Analysis
67 THEOMICS INTERNATIONAL PRIVATE LIMITED: Geographic Presence
68 ArrayGen Technologies : Company Snapshot
69 ArrayGen Technologies : SWOT Analysis
70 ArrayGen Technologies : Geographic Presence
71 D-NOME PRIVATE LIMITED: Company Snapshot
72 D-NOME PRIVATE LIMITED: SWOT Analysis
73 D-NOME PRIVATE LIMITED: Geographic Presence
74 Eurofins, Inc.: Company Snapshot
75 Eurofins, Inc.: SWOT Analysis
76 Eurofins, Inc.: Geographic Presence
77 Genes2Me: Company Snapshot
78 Genes2Me: SWOT Analysis
79 Genes2Me: Geographic Presence
80 Other Companies: Company Snapshot
81 Other Companies: SWOT Analysis
82 Other Companies: Geographic Presence
The Global Personalized Genetic Testing Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Personalized Genetic Testing Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS